be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

Tag filter

stem cells

Holoclar

European Medicines Agency

Most popular

searches

All articles

Filters:

Show search box

2015-03-16

Holoclar – EU’s first stem cell therapy

Holoclar – EU’s first stem cell therapy

European Commission on 17th February 2015 has given conditional marketing authorization of unprecedented medicine in EU. The active substance of Holoclar is the patient’s own limbal stem cells. It is a type of advanced therapy product called a tissue engineered product. It will be implanted to pati... Read more

Tags stem cells , Holoclar , European Medicines Agency